1. The Emerging Role of Long Non-Coding RNAs in Esophageal Cancer: Functions in Tumorigenesis and Clinical Implications
   Yali Han et al, 2022, Frontiers in Pharmacology CrossRef
2. Total Glucosides of Paeony Inhibited Autophagy and Improved Acute Kidney Injury Induced by Ischemia-Reperfusion via the lncRNA TUG1/miR-29a/PTEN Axis
   Xiaoyan Chang et al, 2021, Drug Design, Development and Therapy CrossRef
3. Long Non-Coding RNAs as Competitive Endogenous RNAs in Osteosarcoma
   N. E. Kushlinskii et al, 2020, Molecular Biology CrossRef
4. Selection of lncRNAs That Influence the Prognosis of Osteosarcoma Based on Copy Number Variation Data
   Jian Zhang et al, 2022, Journal of Oncology CrossRef
5. RUNX2 as a promising therapeutic target for malignant tumors
   Weizhu Zhao et al, 2021, Cancer Management and Research CrossRef
6. Serum-Based lncRNA ANRIL, TUG1, UCA1, and HIT Expressions in Breast Cancer Patients
   Ali G. Alkhathami et al, 2022, Disease Markers CrossRef
7. [Retracted] Discovery of New Therapeutic Targets for Osteosarcoma Treatment Based on Immune‐Related lncRNAs in the Tumor Microenvironment
   Ribin Fu et al, 2022, BioMed Research International CrossRef
8. Preoperative Predictors of Early Mortality Risk in People with Osteosarcoma of the Extremities Treated with Standard Therapy
   Ke Tian et al, 2022, Cancer Management and Research CrossRef
9. LncRNA-TUG1 promotes the progression of infantile hemangioma by regulating miR-137/IGFBP5 axis
   Lili Zhou et al, 2021, Human Genomics CrossRef